Αποτελέσματα αναζήτησης - Xuan-Mai Truong Thanh
- Εμφανίζονται 1 - 4 Αποτελέσματα από 4
-
1
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study από Martyn Caplin, Marianne Pavel, Alexandria T. Phan, Jarosław B. Ćwikła, Eva Sedláčková, Xuan-Mai Truong Thanh, Edward M. Wolin, Philippe Ruszniewski
Έκδοση 2020Artigo -
2
SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice—development and results from a pilot study από Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, Philippe Chanson, Stephan Petersenn, Xuan-Mai Truong Thanh, Caroline Sert, Aude Houchard, Isabelle Guillemin, Шломо Мелмед
Έκδοση 2015Artigo -
3
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results από Marianne Pavel, Jarosław B. Ćwikła, Catherine Lombard‐Bohas, Ivan Borbath, Tahir Shah, Ulrich F. Pape, Jaume Capdevila, Francesco Panzuto, Xuan-Mai Truong Thanh, Aude Houchard, Philippe Ruszniewski
Έκδοση 2021Artigo -
4
Preliminary Testing of the Sagit Tool: A Tool to Help Endocrinologists in Their Management of Patients with Acromegaly in Clinical Practice από Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, P. Chanson, Stephan Petersenn, Xuan Mai Truong Thanh, Christine Massien, Carla Dias Barbosa, Isabelle Guillemin, B Arnould, Шломо Мелмед
Έκδοση 2013Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Acromegaly
Growth hormone
Hormone
Internal medicine
Medicine
Clinical Practice
Lanreotide
Adenoma
Adverse effect
Clinical trial
Cohort
Computer science
Depot
Dosing
Endocrinology
Extension (predicate logic)
Family medicine
Gastroenterology
Human physiology
Intensive care medicine
Law
Mathematical economics
Mathematics
Medical physics
Neuroendocrine tumors
Oncology
Open label
Outcome (game theory)
Pediatrics
Physical therapy